Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Idiopathic pulmonary fibrosis: Current and future treatment
Daniel S. Glass, David Grossfeld, Heather A. Renna, et al.
The Clinical Respiratory Journal (2022) Vol. 16, Iss. 2, pp. 84-96
Open Access | Times Cited: 194

Showing 26-50 of 194 citing articles:

Sumatriptan Mitigates Bleomycin-induced Lung Fibrosis in Male Rats: Involvement of Inflammation, Oxidative Stress and α-SMA
Ayda Bahramifar, Razieh Mohammad Jafari, Mohammad Sheibani, et al.
Tissue and Cell (2024) Vol. 88, pp. 102349-102349
Closed Access | Times Cited: 5
A WNT mimetic with broad spectrum FZD-specificity decreases fibrosis and improves function in a pulmonary damage model
Mehaben Patel, Yorick Post, Natalie Hill, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Role of transient receptor potential ankyrin 1 in idiopathic pulmonary fibrosis: modulation of M2 macrophage polarization
Yi Yang, Zhenyu Xiao, Weijie Yang, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
Phospholipids of inhaled liposomes determine the in vivo fate and therapeutic effects of salvianolic acid B on idiopathic pulmonary fibrosis
Jianqing Peng, Qin Wang, Runbin Sun, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 1-15
Closed Access | Times Cited: 5
The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies
Chia‐Chun Tseng, Ya-Wen Sung, Kuan‐Yu Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11995-11995
Open Access | Times Cited: 12
Ginsenosides: a potential natural medicine to protect the lungs from lung cancer and inflammatory lung disease
Lina Wang, Yanxin Zhang, Zhimin Song, et al.
Food & Function (2023) Vol. 14, Iss. 20, pp. 9137-9166
Closed Access | Times Cited: 12
Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
Nikitha Naomi Dsouza, Varun Alampady, Krishnaprasad Baby, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1167-1182
Open Access | Times Cited: 11
An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis
Muhammad Arif, Abhishek Basu, Kaelin M. Wolf, et al.
Advanced Science (2023) Vol. 10, Iss. 16
Open Access | Times Cited: 11
Exploring Extracellular Matrix Crosslinking as a Therapeutic Approach to Fibrosis
S. Lloyd, Yupeng He
(2024)
Open Access | Times Cited: 4
Mechanisms of Bleomycin-induced Lung Fibrosis: A Review of Therapeutic Targets and Approaches
Shaimaa M. Mohammed, Haider Falih Shamikh Al-Saedi, Amjed Qasim Mohammed, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1845-1870
Closed Access | Times Cited: 4
The Fibrotic Phenotype of Human Precision-Cut Lung Slices Is Maintained after Cryopreservation
Méry Marimoutou, Vivek Patel, Jae Hun Kim, et al.
Toxics (2024) Vol. 12, Iss. 9, pp. 637-637
Open Access | Times Cited: 4
Design and development of DSPE-PEG2000/DPPC disk-like micelles for targeted delivery of icariin phytochemical in pulmonary fibrosis
Chengwei Jiang, Satyanarayana Somavarapu
International Journal of Pharmaceutics (2024), pp. 124837-124837
Closed Access | Times Cited: 4
Blood urea nitrogen-to-albumin ratio as a new prognostic indicator of 1-year all-cause mortality in patients with IPF
Shaobo Ge, Yuer Li, Rui Li, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Histological Indicators of Aging at the Cellular Level: Cellular Senescence, Fibrosis, and Regenerative Capacity
Eman Ali Elkordy
Journal of Microscopy and Ultrastructure (2025)
Closed Access
Clinical development complexity of TGF-β inhibition: From fibrosis to cancer immunotherapy
Gabriel Gallo-Oller, María Isabel Guillén-Antonini, Javier Dotor
International review of cell and molecular biology (2025)
Closed Access
The fibronectin-targeting PEG-FUD imaging probe shows enhanced uptake during fibrogenesis in experimental lung fibrosis
Thomas J. Harr, Nikesh Gupta, B. Rahar, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Single-cell transcriptome analysis revealing mechanotransduction via the Hippo/YAP pathway in promoting fibroblast-to-myofibroblast transition and idiopathic pulmonary fibrosis development
Jiaqi Lu, Zhenhua Wang, Liguo Zhang
Gene (2025) Vol. 943, pp. 149271-149271
Closed Access
Bioimpedance Measurements of Fibrotic and Acutely Injured Lung Tissues
Mohammad Mir, Jiawen Chen, Aneri Patel, et al.
Acta Biomaterialia (2025)
Closed Access
Prevention and Treatment of Peritoneal Dialysis-Associated Fibrosis with Intraperitoneal Anti-Fibrotic Therapy in Experimental Peritoneal Fibrosis
Chiao-Yin Sun, Yu‐Ting Hsieh, Shang-Chieh Lu, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 188-188
Open Access
Neutral LPAR1 Antagonists for the Treatment of Idiopathic Pulmonary Fibrosis
Xiaojing Wang
Journal of Medicinal Chemistry (2025)
Closed Access
Traditional Herbal Plants and their Phytoconstituents Based Remedies for Respiratory Diseases: A Review
Lauren Campbell
The Open Respiratory Medicine Journal (2025) Vol. 19, Iss. 1
Open Access
Structural optimization and biological evaluation of indolin-2-one derivatives as novel CDK8 inhibitors for idiopathic pulmonary fibrosis
Jui‐Yi Hsu, Kai‐Cheng Hsu, Ching-Hsuan Chou, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117891-117891
Closed Access
Downregulation of miR-410-3p via the METRNL-mediated AMPK/SIRT1/NF-κB signaling axis inhibits oxidative stress and inflammation in idiopathic pulmonary fibrosis
Tongjie Gu, Ying Zhou, Qiong Wang, et al.
Cellular Signalling (2025), pp. 111667-111667
Closed Access
Novel Synergistic Therapeutic Approach in Idiopathic Pulmonary Fibrosis: Combining the Antifibrotic Nintedanib with the Anti-inflammatory Baricitinib
Qin Wan, Dong‐Dong Li, Shu Shang, et al.
Pulmonary Pharmacology & Therapeutics (2025), pp. 102346-102346
Closed Access
Effect of Sceptridium ternatum Extract (STE) on Radiation-Induced Pulmonary Fibrosis by Inhibiting Cell Adhesion Factor CEACAM1
Yiwen Zhang, Yujia Liu, Xiaoxia Li, et al.
Journal of Ethnopharmacology (2025), pp. 119550-119550
Closed Access

Scroll to top